rs368944411
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_133261.3(GIPC3):c.*15G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000357 in 1,574,412 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00045 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 2 hom. )
Consequence
GIPC3
NM_133261.3 3_prime_UTR
NM_133261.3 3_prime_UTR
Scores
6
Clinical Significance
Conservation
PhyloP100: 0.708
Genes affected
GIPC3 (HGNC:18183): (GIPC PDZ domain containing family member 3) The protein encoded by this gene belongs to the GIPC family. Studies in mice suggest that this gene is required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion in the ear. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.028417945).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000447 (68/152224) while in subpopulation AMR AF= 0.000915 (14/15294). AF 95% confidence interval is 0.000572. There are 0 homozygotes in gnomad4. There are 28 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GIPC3 | NM_133261.3 | c.*15G>A | 3_prime_UTR_variant | 6/6 | ENST00000644452.3 | NP_573568.1 | ||
GIPC3 | NM_001411144.1 | c.967G>A | p.Ala323Thr | missense_variant | 6/6 | NP_001398073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GIPC3 | ENST00000644452.3 | c.*15G>A | 3_prime_UTR_variant | 6/6 | NM_133261.3 | ENSP00000493901 | P1 | |||
GIPC3 | ENST00000644946.1 | c.967G>A | p.Ala323Thr | missense_variant | 6/6 | ENSP00000495068 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152224Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
68
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000278 AC: 51AN: 183668Hom.: 0 AF XY: 0.000262 AC XY: 26AN XY: 99120
GnomAD3 exomes
AF:
AC:
51
AN:
183668
Hom.:
AF XY:
AC XY:
26
AN XY:
99120
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000347 AC: 494AN: 1422188Hom.: 2 Cov.: 35 AF XY: 0.000357 AC XY: 251AN XY: 703778
GnomAD4 exome
AF:
AC:
494
AN:
1422188
Hom.:
Cov.:
35
AF XY:
AC XY:
251
AN XY:
703778
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000447 AC: 68AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.000377 AC XY: 28AN XY: 74350
GnomAD4 genome
AF:
AC:
68
AN:
152224
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
42
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 05, 2015 | The c.*15G>A variant in GIPC3 has not been previously reported in individuals wi th hearing loss. It has been identified 0.13% (26/19782) of European chromosome s by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbS NP rs368944411). This variant occurs in the 3' UTR and its impact is unclear. In summary, the clinical significance of the c.*15G>A variant is uncertain. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MutationTaster
Benign
N
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at